Urinary incontinence
Urinary incontinence is involuntary urine loss classified as stress, urge, mixed, or overflow by history and simple office testing. Stress incontinence is treated with pelvic floor muscle training then a midurethral sling, and urge incontinence/overactive bladder with bladder training then an antimuscarinic or beta-3 agonist, after a postvoid residual and urinalysis exclude overflow and infection.
- Topic reviewThe full article, organized the way the exam asks it.
- ABIM-format MCQsVignettes with an explanation for every wrong answer.
- Key factsThe numbers and thresholds worth memorizing, up front.
- AI tutorMedBrain answers the question you're stuck on.
What this article covers
- Overview
Definition: involuntary loss of urine, classified by mechanism into stress, urge (overactive bladder with incontinence), mixed, overflow, and functional incontinence.
- Epidemiology
Sex distribution: overwhelmingly a condition of women, from pregnancy, vaginal delivery, and menopausal support changes; men develop it chiefly after radical prostatectomy.
- Risk factors
Multiparity and vaginal delivery: the dominant risk factor for stress incontinence through mechanical injury to urethral support and pelvic floor musculature.
- Pathophysiology
Stress incontinence: weakness of the intrinsic urethral sphincter and/or hypermobility of the urethra and bladder neck from lost pelvic floor support lets the urethra open transiently whenever…
- Clinical features
Stress incontinence: small-volume leakage with coughing, sneezing, laughing, or exertion, with no leakage unrelated to position or activity; often follows multiple vaginal deliveries or pelvic/prostate surgery.
- Differential diagnosis
Urinary tract infection: dysuria, new urgency/frequency, and acute-onset incontinence; urinalysis and culture are positive; treat the infection first before attributing symptoms to a chronic incontinence subtype.
- Diagnosis
This is a clinical diagnosis by history and simple office testing, not a single confirmatory lab: classify the subtype from the pattern of leakage (exertional versus urgency-driven versus continuous…
- Management
First, identify and correct a transient reversible cause (DIAPPERS) before committing to a chronic-incontinence pathway: treat a urinary tract infection with an appropriate antibiotic course, hold or…
- Complications
Urinary tract infection (UTI): recurrent infection from incomplete emptying (overflow) or chronic moisture/catheterization needs.
- Prognosis
Behavioral therapy response: pelvic floor muscle training and bladder training outperform pharmacologic therapy for their respective subtypes, with fewer adverse effects, when patients complete a full 6-week trial.
- Prevention
Weight management: counsel weight loss in overweight or obese patients; an 8% BMI reduction cuts incontinence episodes by about 50%.
Read the whole article
Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.
Related articles
- Pelvic organ prolapse
Pelvic organ prolapse is descent of the anterior or posterior vaginal wall, the uterus, or the vaginal cuff into or beyond the vaginal introitus from loss of pelvic floor support. It is a clinical diagnosis made on Valsalva examination; treatment is a vaginal pessary for most patients and compartment-specific reconstructive or obliterative surgery for those who fail or decline conservative care.
- Overactive bladder
Overactive bladder is a clinical diagnosis of urinary urgency, usually with frequency and nocturia, with or without urge incontinence, in the absence of urinary tract infection or another identifiable cause, reflecting involuntary detrusor contraction during bladder filling. First-line treatment is behavioral therapy (bladder training with timed voiding, fluid and bladder-irritant modification), second-line is an antimuscarinic or a beta-3 agonist, and refractory cases proceed to intradetrusor onabotulinumtoxinA or sacral neuromodulation after confirming a normal postvoid residual.
- Neurogenic bladder
Neurogenic bladder is dysfunction of bladder storage or emptying caused by disease or injury of the central or peripheral nervous system, producing either a spastic, high-pressure bladder with urgency incontinence or an atonic, high-volume bladder with retention and overflow incontinence depending on lesion location. Diagnosis rests on the neurologic history and exam with urodynamic testing, and management is centered on a regular, low-pressure emptying regimen, most often clean intermittent catheterization, to protect renal function and prevent infection.
- Genitourinary syndrome of menopause
Genitourinary syndrome of menopause is the chronic, progressive constellation of vulvovaginal and lower urinary tract symptoms caused by estrogen deficiency, presenting with vaginal dryness, dyspareunia, and recurrent urinary symptoms in menopausal women. It is a clinical diagnosis treated first with nonhormonal moisturizers and lubricants, then low-dose vaginal estrogen, with ospemifene or vaginal prasterone reserved as second-line options.
- Vesicovaginal fistula
Vesicovaginal fistula is an abnormal epithelialized tract between the bladder and vagina that produces continuous, painless leakage of urine from the vagina, most often after pelvic surgery (especially hysterectomy) in resource-rich settings or prolonged obstructed labor in resource-limited settings. Small fistulas found early may heal with prolonged bladder (Foley) catheter drainage; established fistulas require surgical closure, timed to let inflammation resolve.
- Obesity
Obesity is a chronic disease of excess adiposity, defined by a body mass index of 30 or greater, that raises risk for type 2 diabetes, cardiovascular disease, sleep apnea, liver disease, and several cancers. Management is staged: lifestyle intervention for all patients, pharmacotherapy after 3 to 6 months of unmet lifestyle goals, and bariatric surgery for a body mass index of 40 or greater or 35 or greater with a comorbidity.
- Constipation
Constipation is infrequent, difficult, or incomplete defecation that is secondary to an identifiable cause, most often a medication, or functional once secondary causes are excluded. Diagnosis rests on alarm-feature screening and Rome IV criteria for the functional subtype, and treatment proceeds stepwise from fiber and osmotic laxatives through secretagogues, prokinetics, biofeedback, or peripheral opioid antagonists.